Condition
Haemodialysis-induced Symptom
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed3
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT01947673Not ApplicableCompleted
Mechanisms of Intradialytic Hypertension
NCT02272985Not ApplicableCompletedPrimary
Cerebral Blood Flow During Hemodialysis
NCT01620580Not ApplicableCompletedPrimary
Symptom Management Program for Hemodialysis Patients
NCT01327560UnknownPrimary
Sleep Quality and Related Factors in Hemodialysis Patients
Showing all 4 trials